 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - GILLIS STEVEN
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-09-19 Purchase | 2019-09-23 8:48 pm | VBI VACCINES Inc | VBIV | GILLIS STEVEN Director | 10,000,000 | $0.5 | $5,000,000 | 13,026,057 (Direct Indirect) | View |
| 2019-02-22 Purchase | 2019-02-26 9:08 pm | Sienna Biopharmaceuticals Inc. | SNNA | ARCH Venture Partners X LLC ARCH Venture Fund X Overage L.P. ARCH Venture Partners X Overage L.P. CRANDELL KEITH NELSEN ROBERT GILLIS STEVEN 10% Owner | 2,165,800 | $2.5 | $5,414,500 | 2,900,575 (Indirect) | View |
| 2018-04-03 Purchase | 2018-04-05 8:27 pm | Pulmatrix Inc. | PULM | GILLIS STEVEN Arch Venture Fund VII LP ARCH Venture Partners VII L.P. ARCH Venture Partners VII LLC CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT Director | 1,150,000 | $0 | $0 | 3,436,456 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-06-14 Exercise | 2019-06-18 4:11 pm | N/A N/A | VBI Vaccines Inc/BC | VBIV | GILLIS STEVEN Director | 18,750 | $0 | 3,026,057 (Direct) | View |
| 2019-06-14 Exercise | 2019-06-18 4:11 pm | N/A N/A | VBI Vaccines Inc/BC | VBIV | GILLIS STEVEN Director | 18,750 | $0 | 3,026,057 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-10 5:09 pm | N/A 2029-06-06 | Homology Medicines Inc. | FIXX | GILLIS STEVEN Director | 15,580 | $19.51 | 15,580 (Direct) | View |
| 2019-05-16 Option Award | 2019-05-20 4:11 pm | N/A 2029-05-16 | Pulmatrix Inc. | PULM | GILLIS STEVEN Director | 15,000 | $1.06 | 15,000 (Direct) | View |
| 2019-01-31 Option Award | 2019-02-04 5:20 pm | N/A 2029-01-31 | VBI Vaccines Inc/BC | VBIV | GILLIS STEVEN Director | 300,000 | $1.67 | 300,000 (Direct) | View |
| 2018-06-14 Exercise | 2018-06-25 9:23 pm | N/A N/A | VBI Vaccines Inc/BC | VBIV | GILLIS STEVEN Director | 18,750 | $0 | 3,026,057 (Direct) | View |
| 2018-06-14 Exercise | 2018-06-25 9:23 pm | N/A N/A | VBI Vaccines Inc/BC | VBIV | GILLIS STEVEN Director | 18,750 | $0 | 3,026,057 (Direct) | View |
| 2018-06-05 Option Award | 2018-06-06 6:00 pm | N/A 2028-06-05 | Pulmatrix Inc. | PULM | GILLIS STEVEN Director | 124,000 | $0.468 | 124,000 (Direct) | View |
| 2018-04-03 Purchase | 2018-04-05 8:27 pm | 2018-04-03 2018-10-03 | Pulmatrix Inc. | PULM | GILLIS STEVEN Arch Venture Fund VII LP ARCH Venture Partners VII L.P. ARCH Venture Partners VII LLC CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT Director | 1,150,000 | $0.65 | 3,436,456 (Indirect) | View |
| 2018-04-03 Purchase | 2018-04-05 8:27 pm | 2018-04-03 2023-04-03 | Pulmatrix Inc. | PULM | GILLIS STEVEN Arch Venture Fund VII LP ARCH Venture Partners VII L.P. ARCH Venture Partners VII LLC CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT Director | 1,150,000 | $0.75 | 3,436,456 (Indirect) | View |
| 2018-04-02 Conversion | 2018-04-04 4:27 pm | N/A N/A | Homology Medicines Inc. | FIXX | GILLIS STEVEN Director | 6,068,695 | $0 | 6,068,695 (Indirect) | View |
| 2018-04-02 Conversion | 2018-04-04 4:27 pm | N/A N/A | Homology Medicines Inc. | FIXX | GILLIS STEVEN Director | 4,683,238 | $0 | 6,068,695 (Indirect) | View |
| 2018-04-02 Conversion | 2018-04-04 4:27 pm | N/A N/A | Homology Medicines Inc. | FIXX | GILLIS STEVEN Director | 1,385,457 | $0 | 6,068,695 (Indirect) | View |
| 2018-03-27 Option Award | 2018-03-29 6:34 pm | N/A 2028-03-27 | Homology Medicines Inc. | FIXX | GILLIS STEVEN Director | 31,160 | $16 | 31,160 (Direct) | View |
| 2018-01-23 Option Award | 2018-01-25 3:42 pm | N/A 2028-01-23 | VBI Vaccines Inc/BC | VBIV | GILLIS STEVEN Director | 100,000 | $4.19 | 100,000 (Direct) | View |